Prosecution Insights
Prosecution Insights
2 pending office actions • 0 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Nanomab Technology Limited has 2 pending office actions currently active in its patent portfolio. These actions are distributed among 2 distinct examiners. AMY MARIE CHATTIN is the busiest examiner, managing 1 pending action.
With 2 pending office actions and 2 distinct examiners, the workload is split evenly, as each examiner is responsible for 1 pending action. This distribution indicates that the portfolio's current prosecution is not concentrated under a single individual at the patent office.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CHATTIN, AMY MARIE | 1 | 73.6% | +44.0% |
| ROONEY, NORA MAUREEN | 1 | 60.3% | +23.6% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18684078 | ANTI-PTK7 SINGLE-DOMAIN ANTIBODY AND APPLICATION THEREOF | CHATTIN, AMY MARIE | — |
| 18575754 | ANTI-TROP2 SINGLE-DOMAIN ANTIBODY AND USE THEREOF | ROONEY, NORA MAUREEN | — |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18684078 | ANTI-PTK7 SINGLE-DOMAIN ANTIBODY AND APPLICATION THEREOF | CHATTIN, AMY MARIE | — | §112 | Non-Final OA | — | Pending | Feb 15, 2024 |
| 18575754 | ANTI-TROP2 SINGLE-DOMAIN ANTIBODY AND USE THEREOF | ROONEY, NORA MAUREEN | — | §112 | Non-Final OA | — | Pending | Dec 29, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial